{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-307964","form_type":"8-K","ticker":"KPTI","cik":"0001503802","company_name":"Karyopharm Therapeutics Inc.","filed_at":"2026-07-17T21:01:30+00:00","discovered_at":"2026-07-17T21:02:00.272051+00:00","generated_at":"2026-07-17T21:02:03.935576+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Karyopharm implements 2026 Leadership Cash Retention Program with $3.715M in total awards to four executives","bullets":["CEO Richard Paulson receives $1.725M; CFO Lori Macomber $625K; CMO Reshma Rangwala $725K; CDO Stuart Poulton $640K.","Program replaces 2026 Annual Bonus Plan guaranteed amounts; awards are lump sum cash.","Awards subject to repayment if executive leaves before 12 months or 30 days post-corporate event, unless termination is without cause, good reason, death/disability.","Retention program aims to incentivize key employees during period of expected catalysts."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-307964","json":"https://secwatch.observer/filing/0001193125-26-307964.json","markdown":"https://secwatch.observer/filing/0001193125-26-307964.md","text":"https://secwatch.observer/filing/0001193125-26-307964.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526307964/0001193125-26-307964-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526307964/d116036d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T21:02:03.935576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}